Weight loss medicines are emerging as a major sales driver for Australia’s major wholesalers and pharmacy operators, with both Sigma Healthcare and Wesfarmers Health citing strong demand for GLP-1 treatments as a contributor to revenue growth.
Weight loss medicines drive revenue growth for Sigma and Wesfarmers Health
August 28, 2026 BioPharmaLatest News
Latest Video
New Stories
-
Eight women named finalists for 2026 Marie Krogh Young Women in Science Prize
September 17, 2026 - - Latest News -
Young Australians badly misjudge when fertility starts to decline, new survey finds
September 16, 2026 - - Latest News -
New research points to a 'Doctor gap' holding back clinical trial participation in Australia
September 16, 2026 - - Latest News -
From constitutional promise to creaking system - the PBS at 80
September 16, 2026 - - Latest News -
A shorter name and bolder blue for Novo in global rebrand
September 15, 2026 - - Latest News -
Australia's 2026 flu vaccination season barely moves the needle on uptake
September 15, 2026 - - Latest News -
Persistent fatigue could be an overlooked sign of liver disease
September 15, 2026 - - Latest News
